Article
Causal relationship between beta-2 microglobulin and B-cell malignancies: genome-wide meta-analysis and a bidirectional two-sample Mendelian randomization study.
Frontiers in immunology - 1 Jan 2024
Li Jiuling, Wu Yao, Zhang Xin, Wang Xueju
Abstract excerpt
Background: Beta-2 microglobulin (β2M) is acknowledged as a prognostic biomarker for B-cell malignancies. However, insights into the impact of β2M on B-cell malignancy risk, and vice versa, are limited. Methods: We conducted a genome-wide meta-analysis (GWMA), bidirectional two-sample Mendelian randomization (TSMR) analysis, and pathway enrichment analysis to explore the causal relationship between β2M and B-cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
